DE EN
DE EN
Home
Research
Studies

DIAN-TU-001

A Phase II/III Randomized, Double‐Blind, Placebo‐Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease

See the information on clinicaltrials.gov

back to overview

Tübingen

DZNE
Local principal investigator: 
Prof. Dr. Christoph Laske
 

Munich

DZNE
Klinikum der Universität München - Neurologische Klinik und Poliklinik
Local principal investigator: 
Prof.Dr. Dr. Johannes Levin

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: 
Imprint |Data Protection